Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

BACKGROUND: In metastatic breast cancer, the status of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), as well as the Ki-67 index sometimes change between primary and metastatic lesions. However, the change in expression levels of enhancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Inari, Hitoshi, Suganuma, Nobuyasu, Kawachi, Kae, Yoshida, Tatsuya, Yamanaka, Takashi, Nakamura, Yoshiyasu, Yoshihara, Mitsuyo, Nakayama, Hirotaka, Yamanaka, Ayumi, Masudo, Katsuhiko, Oshima, Takashi, Yokose, Tomoyuki, Rino, Yasushi, Shimizu, Satoru, Miyagi, Yohei, Masuda, Munetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330119/
https://www.ncbi.nlm.nih.gov/pubmed/28241804
http://dx.doi.org/10.1186/s12885-017-3154-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330119/
https://www.ncbi.nlm.nih.gov/pubmed/28241804
http://dx.doi.org/10.1186/s12885-017-3154-3

Ejemplares similares